324 results on '"Billingsley, Kevin G."'
Search Results
2. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis
3. Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors
4. Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone
5. The patient’s perspective: a qualitative study of individual experience with decision-making, treatment, and recovery for resectable pancreatic cancer
6. Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor
7. Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?
8. Detection of Tumor Multifocality in Resectable Intrahepatic Cholangiocarcinoma: Defining the Optimal Pre-operative Imaging Modality
9. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Clinical Trial
10. Effect of Time to Surgery of Colorectal Liver Metastases on Survival
11. Adjuvant imatinib in high‐risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
12. Reasonable expansion of surgical candidates for HCC treatment
13. ASO Visual Abstract: Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors
14. Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child–Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
15. The Next Step in Tumor Board Evolution: Optimizing Care Coordination and Integration: Editorial on “Integrating a Disease-Focused Tumor Board as a Delivery-of-Care Model to Expedite Treatment Initiation for Patients with Liver Malignancies”
16. ASO Visual Abstract: The Disease-Free Interval is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor
17. Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic
18. Race, Treatment, and Survival of Veterans with Cancer of the Distal Esophagus and Gastric Cardia
19. Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions
20. Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas
21. Preoperative optimization for major hepatic resection
22. Correction to: Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child–Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
23. Hepatopancreatobiliary malignancies: time to treatment matters
24. Modern Technical Approaches in Resectional Hepatic Surgery
25. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis
26. Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
27. Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma.
28. Current Status of Colorectal Cancer Therapy
29. Coagulopathy after a liver resection: is it over diagnosed and over treated?
30. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program
31. Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy
32. Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery
33. Access to High-Volume Hospitals for High-Risk Cancer Surgery for Racial and Ethnic Minoritized Groups
34. Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases
35. Cytokines in Cancer Cachexia
36. Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasm
37. Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors
38. The patient’s perspective: a qualitative study of individual experience with decision-making, treatment, and recovery for resectable pancreatic cancer
39. Chemoradiotherapy with a Radiation Boost for Anal Cancer Decreases the Risk for Salvage Abdominoperineal Resection: Analysis From the National Cancer Data Base
40. Safety and Outcomes Following Resection of Colorectal Liver Metastases in the Era of Current Perioperative Chemotherapy
41. Evolving Preoperative Evaluation of Patients with Pancreatic Cancer: Does Laparoscopy Have a Role in the Current Era?
42. Degree of biliary tract violation during treatment of gallbladder adenocarcinoma is independently associated with development of peritoneal carcinomatosis
43. Conventional hepatic arterial anatomy? Novel findings and insights of a multi-disciplinary hepatic arterial infusion pump program
44. Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
45. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
46. Outcome After Laparoscopic Radiofrequency Ablation of Technically Resectable Colorectal Liver Metastases
47. Does Surgeon Case Volume Influence Nonfatal Adverse Outcomes after Rectal Cancer Resection?
48. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
49. Relevance of Circulating Hybrid Cells as a Non-Invasive Biomarker for Myriad Solid Tumors
50. Outcome following surgical therapy for gastrointestinal stromal tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.